NCT00566098 · OUTCOME
Feasibility of MILs Generation as Assessed by Percentage of Participants With Successful MIL Generation
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- Not reported
- Time frame
- Up to 1 year
What was measured
Success rate of expanding MILs in vitro and obtaining a protocol-specified product.
Groups in this outcome
MILs in Patients Undergoing an Autologous Peripheral SCT
therapeutic autologous lymphocytes therapeutic tumor infiltrating lymphocytes melphalan autologous hematopoietic stem cell transplantation
| Group | Source count |
|---|---|
| MILs in Patients Undergoing an Autologous Peripheral SCT | 22 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| MILs in Patients Undergoing an Autologous Peripheral SCT | 100 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 100
- denoms
- counts
- group Id
- OG000
- value
- 22
- units
- Participants
- description
- Success rate of expanding MILs in vitro and obtaining a protocol-specified product.
- groups
- description
- therapeutic autologous lymphocytes therapeutic tumor infiltrating lymphocytes melphalan autologous hematopoietic stem cell transplantation
- id
- OG000
- title
- MILs in Patients Undergoing an Autologous Peripheral SCT
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- Up to 1 year
- title
- Feasibility of MILs Generation as Assessed by Percentage of Participants With Successful MIL Generation
- type
- PRIMARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle